Pulmonary tuberculosis, oxazolidinones, phase 2b, randomised clinical trial
Sputum microbiome surrogate for respiratory microbiome, anti-tuberculosis antibiotics, tuberculosis treatment, impact on microbiome, anti-tuberculosis drug development strategies.
HIV, early infant diagnosis, point-of-care testing, birth testing, Tanzania, Mozambique